KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,267,000 | +143.6% | 776,510 | +65.2% | 0.00% | +100.0% |
| Q2 2022 | $4,626,000 | -76.7% | 470,133 | -65.1% | 0.00% | -66.7% |
| Q1 2022 | $19,851,000 | -17.2% | 1,346,742 | -25.7% | 0.00% | -25.0% |
| Q4 2021 | $23,966,000 | -25.0% | 1,811,505 | -1.1% | 0.00% | -20.0% |
| Q3 2021 | $31,958,000 | -25.7% | 1,831,441 | +2.1% | 0.01% | -28.6% |
| Q2 2021 | $42,997,000 | +10.9% | 1,794,518 | +18.9% | 0.01% | 0.0% |
| Q1 2021 | $38,767,000 | +133.9% | 1,509,025 | +72.9% | 0.01% | +133.3% |
| Q4 2020 | $16,572,000 | +72.3% | 872,656 | +14.2% | 0.00% | +50.0% |
| Q3 2020 | $9,618,000 | +291.6% | 763,959 | +276.4% | 0.00% | +100.0% |
| Q2 2020 | $2,456,000 | +61.0% | 202,959 | +1.8% | 0.00% | – |
| Q1 2020 | $1,525,000 | -60.6% | 199,315 | -8.2% | 0.00% | -100.0% |
| Q4 2019 | $3,867,000 | +1176.2% | 217,088 | +732.7% | 0.00% | – |
| Q3 2019 | $303,000 | – | 26,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|